{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T19:49:48Z","timestamp":1770839388539,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.ejphar.2013.05.032","type":"journal-article","created":{"date-parts":[[2013,6,20]],"date-time":"2013-06-20T11:32:31Z","timestamp":1371727951000},"page":"157-162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Phenotypic interaction of simultaneously administered isoniazid and phenytoin in patients with tuberculous meningitis or tuberculoma having seizures"],"prefix":"10.1016","volume":"714","author":[{"given":"Prashant S.","family":"Adole","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amandeep","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parampreet S.","family":"Kharbanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadhna","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2013.05.032_bib1","doi-asserted-by":"crossref","first-page":"548","DOI":"10.5414\/CPP40548","article-title":"Determination of the acetylator phenotype in Moroccan tuberculosis patients using isoniazid as metabolic probe","volume":"40","author":"A\u00eft Moussa","year":"2002","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2013.05.032_bib2","first-page":"52","article-title":"Cerebellar atrophy following acute phenytoin intoxication","volume":"27","author":"Alio\u011flu","year":"2000","journal-title":"J. Neuroradiol."},{"key":"10.1016\/j.ejphar.2013.05.032_bib3","first-page":"125","article-title":"Aryl amine N-acetyltransferase 2 polymorphism in the ethnic population of South India","volume":"11","author":"Anitha","year":"2003","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ejphar.2013.05.032_bib4","first-page":"1401","article-title":"Roles of cytochrome P4502C9 and cytochrome P4502C19 in the stereoselective metabolism of phenytoin to its major metabolite","volume":"24","author":"Bajpai","year":"1996","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejphar.2013.05.032_bib5","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1212\/WNL.20.7.687","article-title":"Diphenylhydatoin intoxication attendant to slow inactivation of isoniazid","volume":"20","author":"Brennan","year":"1970","journal-title":"Neurology"},{"key":"10.1016\/j.ejphar.2013.05.032_bib7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.prrv.2007.04.008","article-title":"Clinical manifestations of tuberculosis in children","volume":"8","author":"Cruz","year":"2007","journal-title":"Paediatr. Respir. Rev."},{"key":"10.1016\/j.ejphar.2013.05.032_bib8","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1128\/AAC.45.2.382-392.2001","article-title":"Inhibition of cytochrome P450 (CYP450) isoforms by isoniazid: potent inhibition of CYP2C19 and CYP3A","volume":"45","author":"Desta","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejphar.2013.05.032_bib9","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jinf.2004.02.010","article-title":"Tuberculous meningitis and miliary tuberculosis: the Rich focus revisited","volume":"50","author":"Donald","year":"2005","journal-title":"J. Infect."},{"key":"10.1016\/j.ejphar.2013.05.032_bib10","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/j.1365-3156.2009.02375.x","article-title":"Toxicity of first-line drugs for treatment of tuberculosis in children: review","volume":"14","author":"Frydenberg","year":"2009","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.ejphar.2013.05.032_bib11","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2131\/jts.33.187","article-title":"Effects of N-acetyltransferase 2 (NAT-2), CYP2E1 and glutathione-stransferase (GST) genotypes on serum concentration of isoniazid and its metabolites in tuberculosis patients","volume":"33","author":"Fukino","year":"2008","journal-title":"J. Toxicol. Sci."},{"key":"10.1016\/j.ejphar.2013.05.032_bib12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s002280100268","article-title":"Relative contributions of CYP2C9 and CYP2C19 to phenytoin 4-hydroxylation in vitro: inhibition by sulfaphenazole, omeprazole, and ticlopidine","volume":"57","author":"Giancarlo","year":"2001","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.05.032_bib13","first-page":"29","article-title":"Molecular Genetics and Epidemiology of the NAT1 and NAT2 Acetylation Polymorphisms","volume":"9","author":"Hein","year":"2000","journal-title":"Cancer Epidemiol. Biomarkers Prevent."},{"key":"10.1016\/j.ejphar.2013.05.032_bib14","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1365-2125.1986.tb02897.x","article-title":"A simple method for determining acetylator phenotype using isoniazid","volume":"22","author":"Hutchings","year":"1986","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.05.032_bib15","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S1607-551X(09)70262-1","article-title":"Acute phenytoin intoxication: causes, symptoms, misdiagnosis, and outcomes","volume":"20","author":"Hwang","year":"2004","journal-title":"Kao-Hsiung J. Med. Sci."},{"key":"10.1016\/j.ejphar.2013.05.032_bib16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF00280078","article-title":"Interaction between isoniazid and valproate: a case of valproate overdosage","volume":"40","author":"Jonville","year":"1991","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.05.032_bib17","first-page":"177","article-title":"Simultaneous HPLC measurements of phenobarbitone, phenytoin and carbamazepine from plasma samples","volume":"22","author":"Joshi","year":"1990","journal-title":"Indian J. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.05.032_bib18","first-page":"33","article-title":"Tuberculous meningitis in patients without systemic focus of miliary tuberculosis","volume":"2","author":"Kashyap","year":"2007","journal-title":"Am-Eur. J. Sci. Res"},{"key":"10.1016\/j.ejphar.2013.05.032_bib19","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1212\/WNL.16.6.594","article-title":"Depression of parahydroxylation of diphenyhydatoin by antituberculosis chemotherapy","volume":"16","author":"Kutt","year":"1996","journal-title":"Neuorlogy"},{"key":"10.1016\/j.ejphar.2013.05.032_bib20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF00210758","article-title":"Molecular genotyping of N-acetylation polymorphism to predict phenotype","volume":"90","author":"Mashimo","year":"1992","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ejphar.2013.05.032_bib21","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1378\/chest.75.3.356","article-title":"Clinical importance of interaction of phenytoin and isoniazid: a report from the Boston Collaborative Drug Survieillance Program","volume":"75","author":"Miller","year":"1979","journal-title":"Chest"},{"key":"10.1016\/j.ejphar.2013.05.032_bib22","first-page":"729","article-title":"Outbreak of unexpected reactions among epileptics taking isoniazid","volume":"86","author":"Murray","year":"1962","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.ejphar.2013.05.032_bib23","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1254\/jphs.FP0040296","article-title":"Inhibitory effect of antituberculosis drugs on human cytochrome P450-mediated activities","volume":"96","author":"Nishimura","year":"2004","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2013.05.032_bib24","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/tropej\/42.2.98","article-title":"Long-term anticonvulsant therapy in tuberculous meningitis\u2014a four-year follow-up","volume":"42","author":"Patwari","year":"1996","journal-title":"J. Trop. Pediatr."},{"key":"10.1016\/j.ejphar.2013.05.032_bib25","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0009-9236(97)90115-6","article-title":"Isoniazid acetylation metabolic ratio during maturation in children","volume":"62","author":"Pariente-Khayat","year":"1997","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2013.05.032_bib26","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1365-2125.2005.02529.x","article-title":"Clinically relevant drug interactions with antiepileptic drugs","volume":"61","author":"Perucca","year":"2006","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.05.032_bib27","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1365-2125.2006.02627.x","article-title":"An evaluation of potential mechanism-based inactivation of human drug metabolizing cytochromes P450 by monoamine oxidase inhibitors, including isoniazid","volume":"61","author":"Polasek","year":"2006","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.05.032_bib28","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/00007691-199802000-00009","article-title":"Isoniazid dose adjustment in a pediatric population","volume":"20","author":"Rey","year":"1998","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.ejphar.2013.05.032_bib29","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1128\/CMR.00042-07","article-title":"Central nervous system tuberculosis: pathogenesis and clinical aspects","volume":"21","author":"Rock","year":"2008","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejphar.2013.05.032_bib30","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1093\/hmg\/9.16.2435","article-title":"An update on genetic, structural and functional studies of arylamine N-acetyltransferase in eucaryotes and prokaryotes","volume":"9","author":"Sim","year":"2000","journal-title":"Hum. Mol. Gen."},{"key":"10.1016\/j.ejphar.2013.05.032_bib31","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2490-5-12","article-title":"Genetic polymorphism of the N-acetyltransferase 2 gene and susceptibility to prostate cancer: a pilot study in north Indian population","volume":"5","author":"Srivastava","year":"2005","journal-title":"BMC Urol."},{"key":"10.1016\/j.ejphar.2013.05.032_bib32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0022-3476(75)80066-7","article-title":"Tuberculous meningitis in children during the isoniazid era","volume":"87","author":"Sumaya","year":"1975","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ejphar.2013.05.032_bib33","first-page":"1175","article-title":"Phenytoin toxicity due to concomitant antituberculosis therapy","volume":"85","author":"Walubo","year":"1995","journal-title":"S. Afr. Med. J."},{"key":"10.1016\/j.ejphar.2013.05.032_bib34","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00228-001-0396-3","article-title":"Isoniazid is a mechanism-based inhibitor of cytochrome P450 1A2, 2A6, 2C19 and 3A4 isoforms in human liver microsomes","volume":"57","author":"Wen","year":"2002","journal-title":"Eur. J. Clin. Phramacol"},{"key":"10.1016\/j.ejphar.2013.05.032_bib35","series-title":"Applied Pharmacokinetics: Principles of Therapeutic Drug Monitoring","first-page":"1","article-title":"Phenytoin","author":"Winter","year":"1992"},{"key":"10.1016\/j.ejphar.2013.05.032_bib36","series-title":"Infections of the Central Nervous System","first-page":"417","article-title":"Tuberculosis, second ed., United States","author":"Zuger","year":"1997"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299913004391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299913004391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T13:33:52Z","timestamp":1688304832000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299913004391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":35,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0014299913004391"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2013.05.032","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenotypic interaction of simultaneously administered isoniazid and phenytoin in patients with tuberculous meningitis or tuberculoma having seizures","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2013.05.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}